Cardiovascular consequences of early-onset growth hormone excess.

@article{Colao2002CardiovascularCO,
  title={Cardiovascular consequences of early-onset growth hormone excess.},
  author={Annamaria Colao and Letizia Spinelli and Alberto Cuocolo and Stefano Spiezia and Rosario Pivonello and Carolina Di Somma and Domenico Bonaduce and Mirella Salvatore and Gaetano Lombardi},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2002},
  volume={87 7},
  pages={
          3097-104
        }
}
Acromegaly has relevant effects on the cardiovascular system, but few data deal with the early effects of GH and IGF-I excess. To study the early stage of acromegalic cardiomyopathy and give indirect evidence of the mechanisms underlying GH and IGF-I action on the human heart, 25 patients with uncomplicated acromegaly [15 young subjects with short-term (< or =5 yr) disease and 10 with long-term (>5 yr) disease] and 25 sex- and age-matched controls were studied. Cardiovascular risk parameters… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 33 CITATIONS

Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-analysis of Prospective Interventional Studies.

  • The Journal of clinical endocrinology and metabolism
  • 2018
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Effects of somatostatin analog treatment on cardiovascular parameters in patients with acromegaly: A systematic review

  • Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND

Similar Papers

Loading similar papers…